 | • レポートコード：D0FB0648496 • 出版社/出版日：Prof Research / 2019年12月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：製薬・医療 |
| Single User | ￥420,000 (USD3,000) | ▷ お問い合わせ |
| Site License | ￥532,000 (USD3,800) | ▷ お問い合わせ |
| Global Site License | ￥700,000 (USD5,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| B細胞成熟抗原（BCMA）標的療法のアジア太平洋市場規模は2014～2018年期間中に年平均XX%成長して2018年には$XX millionドルになっており、2019～2024年期間中には年平均XX%成長して2024年までには$XX millionまで成長すると予測されます。本書はB細胞成熟抗原（BCMA）標的療法の市場概要、産業チェーン、市場動向、市場規模予測、需要先情報、関連企業情報などを収録しており、アジアにおけるB細胞成熟抗原（BCMA）標的療法市場の詳細な情報を探している方にとって有用な参考資料です。日本、中国、インド、韓国、インドネシア、マレーシア、フィリピン、タイ、ベトナム、シンガポール、オーストラリアなどを地域を対象にしています。 ・市場概要 ・産業チェーン分析（ファイブフォース分析、コスト構造分析） ・市場動向 ・B細胞成熟抗原（BCMA）標的療法のアジア市場規模推移2014-2019 ・B細胞成熟抗原（BCMA）標的療法のアジア市場規模予測2019-2024 ・B細胞成熟抗原（BCMA）標的療法のサプライヤー分析 ・顧客（需要先）分析 ・主要企業分析（Transposagen Biopharmaceuticals、Sutro Biopharma、Malin Corporation、Eureka Therapeutics、firstVentury Equity、Five Prime Therapeutics、Credit Suisse Securities、Dana-Farber Cancer Institute、Deerfiel） ・結論 |
Abstract:
The Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024.
This report is an essential reference for who looks for detailed information on Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies market. The report covers data on Asia Pacific markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as Asia Pacific major vendors¡¯ information. In addition to the data part, the report also provides overview of B-Cell Maturation Antigen(BCMA) Targeted Therapies market, including classification, application, manufacturing technology, industry chain analysis and latest market dynamics. Finally, a customization report in order to meet user’s requirements is also available.
Key Points of this Report:
* The depth industry chain include analysis value chain analysis, porter five forces model analysis and cost structure analysis
* The report covers Asia Pacific and country-wise market of B-Cell Maturation Antigen(BCMA) Targeted Therapies
* It describes present situation, historical background and future forecast
* Comprehensive data showing B-Cell Maturation Antigen(BCMA) Targeted Therapies capacities, production, consumption, trade statistics, and prices in the recent years are provided
* The report indicates a wealth of information on B-Cell Maturation Antigen(BCMA) Targeted Therapies manufacturers
* B-Cell Maturation Antigen(BCMA) Targeted Therapies market forecast for next five years, including market volumes and prices is also provided
* Raw Material Supply and Downstream Consumer Information is also included
* Any other user’s requirements which is feasible for us
The largest vendors of Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies market: (At least 9 companies included)
* Transposagen Biopharmaceuticals
* Sutro Biopharma
* Malin Corporation
* Eureka Therapeutics
* firstVentury Equity
* Five Prime Therapeutics
For complete list, please ask for sample pages.
The B-Cell Maturation Antigen(BCMA) Targeted Therapies market in Asia Pacific is segmented by countries:
* China
* India
* Japan
* South Korea
* Bangladesh
* Sri Lanka
* Indonesia
* Malaysia
* Philippines
* Thailand
* Vietnam
* Singapore
* Australia
* New Zealand
The reports analysis B-Cell Maturation Antigen(BCMA) Targeted Therapies market in Asia Pacific by products type:
* Type I
* Type II
* Type III
The reports analysis B-Cell Maturation Antigen(BCMA) Targeted Therapies market in Asia Pacific by application as well:
* Application I
* Application II
* Application III
Reasons to Purchase this Report:
* Analyzing the outlook of the market with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Distribution Channel sales Analysis by Value
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.
Any special requirements about this report, please let us know and we can provide custom report.
レポート目次Table of Contents
Chapter One B-Cell Maturation Antigen(BCMA) Targeted Therapies Overview
1.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Outline
1.2 Classification and Application
1.3 Manufacturing Technology
Chapter Two Industry Chain Analysis
2.1 Value Chain Analysis
2.2 Porter Five Forces Model Analysis
2.3 Cost Structure Analysis
Chapter Three Market Dynamics of B-Cell Maturation Antigen(BCMA) Targeted Therapies Industry
3.1 Latest News and Policy
3.2 Market Drivers
3.3 Market Challenges
Chapter Four Asia Pacific Market of B-Cell Maturation Antigen(BCMA) Targeted Therapies (2014-2019)
4.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Supply
4.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size
4.3 Import and Export
4.4 Demand Analysis
4.5 Market Competition Analysis
4.6 Price Analysis
4.7 Country-wise Analysis
Chapter Five Asia Pacific Market Forecast (2019-2024)
5.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Supply
5.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size
5.3 Import and Export
5.4 Demand Analysis
5.5 Market Competition Analysis
5.6 Price Analysis
5.7 Country-wise Analysis
Chapter Six Asia Pacific Raw Material Supply Analysis
6.1 Raw Material Supply
6.2 Raw Material Producers Analysis
6.3 Analysis of the Influence of Raw Material Price Fluctuation
Chapter Seven Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumer Analysis
7.1 Asia Pacific Major Consumers Information
7.2 Asia Pacific Major Consumer Demand Analysis
Chapter Eight Analysis of Asia Pacific Key Manufacturers (Including Company Profile, SWOT Analysis, Production Information etc.)
8.1 Transposagen Biopharmaceuticals
8.2 Sutro Biopharma
8.3 Malin Corporation
8.4 Eureka Therapeutics
8.5 firstVentury Equity
……
……
Chapter Nine Research Conclusions of Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Industry
Tables and Figures
Figure Commercial Product of B-Cell Maturation Antigen(BCMA) Targeted Therapies
Table Classification of B-Cell Maturation Antigen(BCMA) Targeted Therapies
Table Application of B-Cell Maturation Antigen(BCMA) Targeted Therapies
Figure Porter Five Forces Model Analysis of Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies
Figure Production Cost Analysis of Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies
Table B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Drivers & Market Challenges
Table 2014-2019 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity List
Table 2014-2019 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Manufacturers Capacity Share List
Figure 2014-2019 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Manufacturers Capacity Share
Table 2014-2019 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Manufacturers Production List
Table 2014-2019 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Manufacturers Production Share List
Figure 2014-2019 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Manufacturers Production Share
Figure 2014-2019 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity Production and Growth Rate
Table 2014-2019 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Manufacturers Production Value (Million USD) List
Figure 2014-2019 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Value and Growth Rate
Table 2014-2019 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Manufacturers Production Value Share List
Figure 2014-2019 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Manufacturers Production Value Share List
Table 2014-2019 Asia Pacific Supply and Consumption of B-Cell Maturation Antigen(BCMA) Targeted Therapies
Table 2014-2019 Asia Pacific Import and Export of B-Cell Maturation Antigen(BCMA) Targeted Therapies
Table 2014-2019 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Demand List by Application
Figure 2014-2019 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Demand by Application
Table 2014-2019 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Demand Share List by Application
Figure 2014-2019 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Demand Share by Application
Table 2014-2019 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Country-wise Consumption List
Figure 2014-2019 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Country-wise Consumption
Table 2014-2019 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Country-wise Consumption Share List
Figure 2014-2019 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Country-wise Consumption Share
Table 2014-2019 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity Production Cost Profit and Gross Margin List
Table 2019-2024 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity List
Table 2019-2024 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Manufacturers Capacity Share List
Figure 2019-2024 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Manufacturers Capacity Share
Table 2019-2024 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Manufacturers Production List
Table 2019-2024 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Manufacturers Production Share List
Figure 2019-2024 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Manufacturers Production Share
Figure 2019-2024 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity Production and Growth Rate
Figure 2019-2024 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Value and Growth Rate
Table 2019-2024 Asia Pacific Supply and Consumption of B-Cell Maturation Antigen(BCMA) Targeted Therapies
Table 2019-2024 Asia Pacific Import and Export of B-Cell Maturation Antigen(BCMA) Targeted Therapies
Table 2019-2024 Asia Pacific Demand of B-Cell Maturation Antigen(BCMA) Targeted Therapies by Application
Figure 2019-2024 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Demand by Application
Table 2019-2024 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Demand Share List by Application
Figure 2019-2024 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Demand Share by Application
Table 2019-2024 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Country-wise Consumption List
Figure 2019-2024 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Country-wise Consumption
Table 2019-2024 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Country-wise Consumption Share List
Figure 2019-2024 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Country-wise Consumption Share
Table 2019-2024 Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity Production Cost Profit and Gross Margin List
Table Asia Pacific B-Cell Maturation Antigen(BCMA) Targeted Therapies Raw Material Suppliers
Table Key End Users List
Table Profile of Transposagen Biopharmaceuticals
Table SWOT Analysis of Transposagen Biopharmaceuticals
Table Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Specification
Table 2014-2019 Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity Production and Growth Rate
Figure 2014-2019 Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Global Market Share
Table SWOT Analysis of Sutro Biopharma
Figure Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Products
Table 2014-2019 Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity Production and Growth Rate
Figure 2014-2019 Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Global Market Share
Table SWOT Analysis of Malin Corporation
Figure Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Product
Table Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Specification
Table 2014-2019 Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity Production and Growth Rate
Figure 2014-2019 Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Global Market Share
Table Profile of Eureka Therapeutics
Table SWOT Analysis of Eureka Therapeutics
Figure Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Product
Table Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Specification
Table 2014-2019 Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity Production and Growth Rate
Figure 2014-2019 Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Global Market Share
Table Profile of firstVentury Equity
Table SWOT Analysis of firstVentury Equity
Figure firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Product
Table 2014-2019 firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Capacity Production Price Cost Production Value List
Figure 2014-2019 firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity Production and Growth Rate
Figure 2014-2019 firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Global Market Share
……
……
癌胎児性抗原関連細胞接着分子5のアジア市場：市場規模・シェア・価格・動向・予測 Abstract: The Asia Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024. This report is an essential reference for w…- 標的癌薬のアジア市場：市場規模・シェア・価格・動向・予測 Abstract: The Asia Pacific Targeted Cancer Drugs market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024. This report is an essential reference for who looks for detailed information on…
- 標的DNA / RNAシーケンスのアジア市場：市場規模・シェア・価格・動向・予測 Abstract: The Asia Pacific Targeted DNA/RNA Sequencing market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024. This report is an essential reference for who looks for detailed informat…
- 再生療法のアジア市場：市場規模・シェア・価格・動向・予測 Abstract: The Asia Pacific Regenerative Therapies market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024. This report is an essential reference for who looks for detailed information o…
- 癌治療のアジア市場：市場規模・シェア・価格・動向・予測 Abstract: The Asia Pacific Cancer Therapies market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024. This report is an essential reference for who looks for detailed information on Asia…